Survodutide Protocol
Dosing & Research
Last Updated: August 30, 2026
Chemical Identity
- Molecular Formula
- C192H289N47O61
- Molecular Weight
- 4231.69 g/mol
- CAS Number
- 2805997-46-8
Obesity/NAFLD research, GLP-1/glucagon dual agonism, Liver-fat reduction studies, Weight-management trials
Half-Life
Long-acting; supports once-weekly dosing
Administration
Subcutaneous
Frequency
Once Or Twice Weekly, Same Day(s) Each Week
How It Works
- Obesity/NAFLD research
- GLP-1/glucagon dual agonism
- Liver-fat reduction studies
- Weight-management trials
Dosing Structure
Dose
0.3mg-6mg weekly (titrated)
Frequency
Once Or Twice Weekly, Same Day(s) Each Week
Notes
1x Weekly titration: Week 1-4: 0.3mg | Week 5-8: 0.6mg | Week 9-12: 1.2mg | Week 13-16: 2.4mg | Week 17-20: 3.6mg | Week 21-24: 4.8mg | Week 25+: 6mg. 2x Weekly titration: Week 1-4: 0.15mg | Week 5-8: 0.3mg | Week 9-12: 0.6mg | Week 13-16: 1.2mg | Week 17-20: 1.8mg | Week 21-24: 2.4mg | Week 25+: 3mg. No need to increase dose if experiencing benefits. Inject: Abdomen (2+ inches from navel), upper thigh, or upper arm. Any time of day with or without food. Typically follows a weekly titration schedule.
Example Protocols
Dose: 0.3mg-6mg weekly (titrated)
Frequency: Once Or Twice Weekly, Same Day(s) Each Week
Duration: Long-term Continuous Weekly Treatment
Off Period: Not listed
Find Research Grade Survodutide
Recommended vendors for sourcing research-grade material. PeptaBase does not sell peptides directly.
Vendor One Research Labs
COA VerifiedThird-party COA-verified research peptides with published batch testing.
Source Coming SoonVendor Two Sciences
Purity TestedUS-based research compound supplier with independent purity testing.
Source Coming SoonVendor Three Peptide Co.
Bulk research peptide sourcing with batch-level documentation.
Source Coming SoonProtocol Notes
1x Weekly titration
Week 1-4: 0.3mgWeek 5-8: 0.6mgWeek 9-12: 1.2mgWeek 13-16: 2.4mgWeek 17-20: 3.6mgWeek 21-24: 4.8mgWeek 25+: 6mg
2x Weekly titration
Week 1-4: 0.15mgWeek 5-8: 0.3mgWeek 9-12: 0.6mgWeek 13-16: 1.2mgWeek 17-20: 1.8mgWeek 21-24: 2.4mgWeek 25+: 3mg
•
No need to increase dose if experiencing benefits.
•
Inject: Abdomen (2+ inches from navel), upper thigh, or upper arm.
•
Any time of day with or without food.
•
Typically follows a weekly titration schedule.
Research & Studies
Loading citations…
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Be the first to submit research feedback for this peptide.
Approved submissions will appear here as aggregated insights.